Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
The purpose of the study is to determine safety and efficacy of an oral contraceptive in
 treating acne papulopustulosa.
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been
 renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor
 of the trial.
Inclusion Criteria:

 -  Patients with mild to moderate facial papulopustular acne

 Exclusion Criteria:

 -  Contraindication against use of hormonal contraceptives